DK3172317T3 - Fremgangsmåde til oprensning af poliovirus fra cellekulturer - Google Patents
Fremgangsmåde til oprensning af poliovirus fra cellekulturer Download PDFInfo
- Publication number
- DK3172317T3 DK3172317T3 DK15741534.0T DK15741534T DK3172317T3 DK 3172317 T3 DK3172317 T3 DK 3172317T3 DK 15741534 T DK15741534 T DK 15741534T DK 3172317 T3 DK3172317 T3 DK 3172317T3
- Authority
- DK
- Denmark
- Prior art keywords
- poliovirus
- cleaning
- procedure
- cell cultures
- cultures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32351—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32651—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14178392 | 2014-07-24 | ||
| EP14178399 | 2014-07-24 | ||
| PCT/EP2015/066638 WO2016012445A2 (en) | 2014-07-24 | 2015-07-21 | Process for the purification of poliovirus from cell cultures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3172317T3 true DK3172317T3 (da) | 2019-07-22 |
Family
ID=53719768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15741534.0T DK3172317T3 (da) | 2014-07-24 | 2015-07-21 | Fremgangsmåde til oprensning af poliovirus fra cellekulturer |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10294460B2 (da) |
| EP (1) | EP3172317B1 (da) |
| JP (1) | JP6385559B2 (da) |
| KR (1) | KR102364111B1 (da) |
| CN (1) | CN106574252B (da) |
| AU (1) | AU2015294014B2 (da) |
| BR (1) | BR112017001177B1 (da) |
| CA (1) | CA2955877A1 (da) |
| DK (1) | DK3172317T3 (da) |
| EA (1) | EA034503B1 (da) |
| ES (1) | ES2733489T3 (da) |
| PL (1) | PL3172317T3 (da) |
| SG (1) | SG11201700361QA (da) |
| WO (1) | WO2016012445A2 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3172317B1 (en) | 2014-07-24 | 2019-05-01 | Janssen Vaccines & Prevention B.V. | Process for the purification of poliovirus from cell cultures |
| WO2016201224A1 (en) | 2015-06-10 | 2016-12-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Processes for production and purification of nucleic acid-containing compositions |
| MX2019002495A (es) * | 2016-09-01 | 2020-02-17 | Takeda Vaccines Inc | Metodos para producir virus para la produccion de vacunas. |
| WO2019155492A1 (en) * | 2018-02-07 | 2019-08-15 | Bharat Biotech International Limited | A process for enterovirus purification and inactivation and vaccine compositions obtained thereof |
| WO2022132988A1 (en) * | 2020-12-17 | 2022-06-23 | Merck Sharp & Dohme Corp. | Enterovirus purification with cation exchange chromatography |
| JP2023141423A (ja) * | 2022-03-24 | 2023-10-05 | 国立大学法人 東京大学 | ウイルスの精製方法 |
| CN116987676B (zh) * | 2023-09-27 | 2023-12-19 | 深圳源兴基因技术有限公司 | 一种微载体痘病毒高效培养方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4525349A (en) | 1981-12-29 | 1985-06-25 | Societe Anonyme Dite: Institut Merueux | Process for the large-scale production of a vaccine against poliomyelitis and the resulting vaccine |
| ES2333425T5 (es) | 1995-06-15 | 2012-08-28 | Crucell Holland B.V. | Sistemas de empaquetado para adenovirus recombinante humano destinados a terapia génica |
| GB0002661D0 (en) | 2000-02-04 | 2000-03-29 | Biomade B V | Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin |
| BR0207527A (pt) | 2001-03-16 | 2004-02-25 | Oncolytics Biotech Inc | Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso |
| ES2357366T3 (es) | 2002-05-14 | 2011-04-25 | MERCK SHARP & DOHME CORP. | Procedimientos de purificación de adenovirus. |
| CN1777622A (zh) * | 2003-02-24 | 2006-05-24 | 施里昂药品股份公司 | 脊髓灰质炎病毒受体功能的调节 |
| DE602004024964D1 (de) * | 2003-03-10 | 2010-02-25 | Novozymes As | Verfahren zur herstellung von alkohol |
| EP1613729A1 (en) * | 2003-04-04 | 2006-01-11 | Novozymes A/S | Mash viscosity reduction |
| JP2004313019A (ja) | 2003-04-11 | 2004-11-11 | Mitsubishi Kagaku Iatron Inc | 組織抽出液の製造方法 |
| WO2004099396A1 (en) | 2003-05-09 | 2004-11-18 | Crucell Holland B.V. | Cultures of e1-immortalized cells and processes for culturing the same to increase product yields therefrom |
| AU2005214090B2 (en) * | 2004-02-23 | 2008-09-11 | Crucell Holland B.V. | Virus purification methods |
| ES2456015T3 (es) | 2004-03-05 | 2014-04-21 | Dsm Ip Assets B.V. | Procedimiento para cultivar células mediante perfusión continua y flujo tangencial alternante |
| EP1793852A1 (en) | 2004-08-27 | 2007-06-13 | Panacea Biotec Ltd. | Inactivated poliomyelitis vaccine derived from sabin strain of polio virus |
| US7901921B2 (en) * | 2004-10-22 | 2011-03-08 | Oncolytics Biotech Inc. | Viral purification methods |
| CN101155915B (zh) * | 2005-04-11 | 2013-12-04 | 克鲁塞尔荷兰公司 | 利用超滤进行病毒纯化 |
| US7968318B2 (en) * | 2006-06-06 | 2011-06-28 | Genencor International, Inc. | Process for conversion of granular starch to ethanol |
| PT2634250T (pt) | 2006-07-14 | 2017-07-13 | Patheon Holdings I B V | Processo melhorado para a cultura de células |
| AU2010272685B2 (en) | 2009-07-16 | 2015-02-26 | Crucell Holland B.V. | Production of polio virus at high titers for vaccine production |
| AU2010305765B2 (en) * | 2009-10-15 | 2015-07-02 | Crucell Holland B.V. | Method for the purification of adenovirus particles |
| CN102575233B (zh) | 2009-10-15 | 2014-07-16 | 克鲁塞尔荷兰公司 | 从高细胞密度培养物纯化腺病毒的方法 |
| EP2461162A1 (en) * | 2010-12-03 | 2012-06-06 | Texcell, . | Method for determining the titre of viruses by using infectious standards |
| RU2013153507A (ru) | 2011-06-06 | 2015-07-20 | Биокарти Нв | Селективный лизис клеток с помощью ионных поверхностно-активных веществ |
| EP3172317B1 (en) | 2014-07-24 | 2019-05-01 | Janssen Vaccines & Prevention B.V. | Process for the purification of poliovirus from cell cultures |
-
2015
- 2015-07-21 EP EP15741534.0A patent/EP3172317B1/en active Active
- 2015-07-21 KR KR1020177004968A patent/KR102364111B1/ko active IP Right Grant
- 2015-07-21 JP JP2017503831A patent/JP6385559B2/ja active Active
- 2015-07-21 DK DK15741534.0T patent/DK3172317T3/da active
- 2015-07-21 WO PCT/EP2015/066638 patent/WO2016012445A2/en active Application Filing
- 2015-07-21 EA EA201790250A patent/EA034503B1/ru not_active IP Right Cessation
- 2015-07-21 CN CN201580041014.0A patent/CN106574252B/zh active Active
- 2015-07-21 PL PL15741534T patent/PL3172317T3/pl unknown
- 2015-07-21 BR BR112017001177-8A patent/BR112017001177B1/pt active IP Right Grant
- 2015-07-21 CA CA2955877A patent/CA2955877A1/en active Pending
- 2015-07-21 ES ES15741534T patent/ES2733489T3/es active Active
- 2015-07-21 SG SG11201700361QA patent/SG11201700361QA/en unknown
- 2015-07-21 US US15/325,650 patent/US10294460B2/en active Active
- 2015-07-21 AU AU2015294014A patent/AU2015294014B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3172317A2 (en) | 2017-05-31 |
| SG11201700361QA (en) | 2017-02-27 |
| US20170166872A1 (en) | 2017-06-15 |
| CN106574252A (zh) | 2017-04-19 |
| BR112017001177B1 (pt) | 2022-05-24 |
| CA2955877A1 (en) | 2016-01-28 |
| US10294460B2 (en) | 2019-05-21 |
| KR20170031242A (ko) | 2017-03-20 |
| ES2733489T3 (es) | 2019-11-29 |
| WO2016012445A3 (en) | 2016-03-31 |
| PL3172317T3 (pl) | 2019-10-31 |
| KR102364111B1 (ko) | 2022-02-17 |
| AU2015294014B2 (en) | 2018-08-23 |
| CN106574252B (zh) | 2021-06-01 |
| JP6385559B2 (ja) | 2018-09-05 |
| BR112017001177A2 (pt) | 2017-11-21 |
| EA034503B1 (ru) | 2020-02-14 |
| AU2015294014A1 (en) | 2017-01-12 |
| JP2017524360A (ja) | 2017-08-31 |
| EP3172317B1 (en) | 2019-05-01 |
| WO2016012445A2 (en) | 2016-01-28 |
| EA201790250A1 (ru) | 2017-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3186376T3 (da) | Fremgangsmåder til forbedring af cas9-medieret manipulationseffektivitet | |
| DK3165507T3 (da) | Fremgangsmåde til fremstilling af porøs grafen | |
| DK3926051T3 (da) | Fremgangsmåder til høst af pattedyrecellekulturer | |
| DK3134506T3 (da) | Fremgangsmåder til oprensning af messenger rna | |
| DK3757214T3 (da) | Sammensætninger til modulering af sod-1-ekspression | |
| DK3110988T3 (da) | Metoder til behandling af lithiumholdige materialer | |
| DE112015005834A5 (de) | Wasserdurchlässiges Bodengitter für Pflasterungen | |
| DK3116902T3 (da) | Fremgangsmåde til generering af T-celler kompatible for allogen transplantation | |
| DK3096741T3 (da) | Fremgangsmåde til fremstillingen af hybridosomer | |
| DK3294700T3 (da) | Fremgangsmåde til fremstilling af limonen-4-ol | |
| MA40254A (fr) | Polymorphes du selinexor | |
| DK3174858T3 (da) | Fremgangsmåde til fremstilling af pyrazoler | |
| BR112017009540A2 (pt) | biorreator usando macroalgas | |
| DK3122444T3 (da) | Fremgangsmåde til fremstilling af membraner | |
| DK3172233T3 (da) | Anti-cd74-antistoffer, sammensætninger omfattende anti-cd74- antistoffer og fremgangsmåder til anvendelse af anti-cd74-antistoffer | |
| DK2966044T3 (da) | Fremgangsmåde til fremstilling af skumglas | |
| DK3125898T3 (da) | Farmakofor til trail-induktion | |
| DK3102936T3 (da) | Fremgangsmåde til onlinemonitorering af vandkvalitet | |
| DK3172317T3 (da) | Fremgangsmåde til oprensning af poliovirus fra cellekulturer | |
| DK3158141T3 (da) | Til udskiftlige modulære monteringer | |
| DK3183237T3 (da) | Fremgangsmåde til fremstilling af 5-fluor-1h-pyrazoler startende ud fra hexafluorpropen | |
| DK3222717T3 (da) | Fremgangsmåde til at amplificere cirkulært dna | |
| DK3174394T3 (da) | Fremgangsmåde til plantepodning | |
| DK3124651T3 (da) | Indretning til fremstilling af organisk hydrid | |
| DK3365436T3 (da) | Fremgangsmåder til fremstilling af en primær celleprøve |